Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
Rite Aid said U.S. Bankruptcy Court has approved the sale of its Elixir pharmacy benefit management (PBM) company to MedImpact for $575 million. Rite Aid is selling its Elixir pharmacy benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback